dialysispatients〔J〕．GeriatrGerontolInt，2009;9(3):246-52．2AdragaoT，HerberthJ，Monier-FaugereMC，etal．Lowbonevolumeariskfactorforcoronarycalcificationsinhemodialysispatients〔J〕．ClinJAmSocNephrol，2009;4(2):450-5．3KwonA，ChoiYS，ChoiYW，etal．Serumosteoprote-gerinisassociat-edwithcalcifiedcarotidplaque〔J〕．Medicine(Baltimore)，2016;95(15):e3381-7．4OsakoMK，NakagamiH，ShimamuraM，etal．Cross-talkofreceptoractivatorofnuclearfactor-κBligandsignalingwithrenin-angiotensinsysteminvascularcalcification〔J〕．ArteriosclerThrombVascBiol，2013;33(6):1287-96．5ZhouＲ，ZhouH，CuiM，etal．AssociationbetweenaorticcalcificationandtheriskofosteoporosisinaChinesecohort:thechongqingosteo-porosisstudy〔J〕．CalcifTissInt，2013;93(5):419-25．6AtoD，SawayamaT．Factorsassociatedwithhighbrachialanklepulsewavevelocityinnon-hypertensiveandappropriatelytreatedhyperten-sivepatientswithatheroscleroticriskfactors〔J〕．VascHealthＲiskManag，2017;13:383-92．7KavousiM，Elias-SmaleS，ＲuttenJH，etal．Evaluationofnewerriskmarkersforcoronaryheartdiseaseriskclassification:acohortstudy〔J〕．AnnInternMed，2012;156(6):438-44．8文娱，陈雪梅．骨保护素在临床中的应用进展〔J〕．中国当代医药，2013;20(3):12-3．9ZhaoH，GuJ，DaiN，etal．Osteoprotegerinexposureatdifferentstagesofosteoclastogenesisdifferentiallyaffectsosteoclastformationandfunction〔J〕．Cytotechnology，2016;68(4):1325-35．10KownA，ChoiYS，ChoiYW，etal．Serumoestoprotegerinisassociat-edwithcalifiedcartiodplaque:astrob-compliantobservationalstudy〔J〕．Medicine，2016;95(16):380-1．11DavenportC，MahmoodWA，FordeH，etal．Theeffectsofinsulinandliraglutideonosteoprotegerinandvascularcalcificationinvitroandinpatientswithtype2diabetes〔J〕．EurJEndocrinol，2015;173(1):53-61．12TousoulisD，SiasiosG，ManiatisK，etal．Serumosteoprotegerinandosteopontinlevelsandthepresenceandseverityofcoronaryarterydisease〔J〕．IntCardiol，2013;167(5):1924-8．13时超楠，李雪梓，刘玲玲．绝经后妇女血清鸢尾素与骨密度和骨代谢的相关性研究〔J〕．中国骨质疏松杂志，2...
